“…For proof-of-principle studies, we focused on NIH 3T3 fibroblasts, which have been mechanically characterized by AFM (46,47), optical stretching (48,49), and MPA (50). To explore the potential of our cross-slot device for novel discovery, we also characterized GBM TICs, a stem-like subpopulation of GBM tumors thought to drive tumor initiation, recurrence, and therapeutic resistance (26,51,52).…”